Structure |
Chemical Name |
CAS |
MF |
|
Avatrombopag Impurity 34 |
|
|
|
3-Chloro Avanafil |
|
|
|
Avanafil IMpurity 8 (R-Avanafil) |
|
|
|
5-クロロ-6-[4-(エトキシカルボニル)ピペリジノ]ニコチン酸 |
931395-73-2 |
C14H17ClN2O4 |
|
Avanafil Impurity 10 |
|
|
|
Adefovir Impurity 2 |
|
|
|
Abacavir Impurity F |
1443421-68-8 |
C18H26N6O |
|
Albendazole EP Impurity J |
946498-41-5 |
C9H7Cl2N3O2 |
|
Abitrone project impurity |
|
|
|
1364671-52-2 |
1364671-52-2 |
C19H19ClN6O3S |
|
Sugammadex disulfide Impurity |
|
|
|
2-Thiazolamine, 5-bromo-4-(5-bromo-4-chloro-2-thienyl)- |
2401867-89-6 |
C7H3Br2ClN2S2 |
|
Avatrombopag Impurity 31 |
|
|
|
Abiraterone Sulfate |
|
|
|
Avanafil iMpurity 5 |
|
|
|
Adefovir Dipivoxil Impurity E |
116384-54-4 |
C10H16N5O4P |
|
Adefovir Impurity 6 |
|
|
|
N - hydroxy Tropisetron Impurity 2 |
|
|
|
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo- |
762237-66-1 |
C23H25Cl2N5O2S2 |
|
Amoxicillin EP Impurity K |
|
C16H19N3O5S |
|
Apixaban Degradation of Impurity |
|
|
|
Afatinib Impurity 52 |
|
|
|
Afatinib Impurity 67 |
|
|
|
Alogliptin Impurity 30 |
|
|
|
Afatinib Impurity 77 |
26404-20-6 |
C5H7ClO3 |
|
Azlocillin Opern-Ring Impurity |
96688-41-4 |
C20H25N5O7S |
|
AMOXICILLIN TRIHYDRATE IMP. C (EP): (4S)-2-[5-(4-HYDROXYPHENYL)-3,6-DIOXOPIPERAZIN-2-YL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID (AMOXICILLIN DIKETOPIPERAZINES) |
|
|
|
2-Piperidinone, 3-chloro-1-(4-nitrophenyl)- |
2512213-45-3 |
C11H11ClN2O3 |
|
Anastrozole Impurity 14 |
|
|
|
Ethyl 5,6-dichloro-3,4-dihydro-2(1H)-iminoquinazoline-3-acetate hydrobromide |
70381-75-8 |
C12H14BrCl2N3O2 |
|
methyl 5-((4-(3-carbamoyl-1-(4-methoxyphenyl)-7-oxo-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)phenyl)amino)pentanoate |
|
|
|
α-Desmethyl Anastrozole |
1215780-15-6 |
C16H17N5 |
|
Anastrozole iMpurityC |
|
|
|
2-Deschloro Aripiprazole |
203395-82-8 |
C23H28ClN3O2 |
|
AMoxicillin iMpurity K |
|
C16H19N3O5S |
|
R-afatinib |
945553-91-3 |
C24H25ClFN5O3 |
|
Acarbose Impurity A |
|
|
|
2-[[6-[(3R)-3-tert-butoxycarbonylamino-1-piperidinyl]-3,4-dihydro-2,4-dioxo-3-methyl-1(2H)-pyrimidinyl]methyl]benzonitrile |
1246610-74-1 |
C23H29N5O4 |
|
Brexpiprazole Impurity 15 |
|
|
|
Amoxicillin Impurity O |
|
C16H19N3O5S |
|
7-Hydroxy Alosetron |
863485-44-3 |
C17H18N4O2 |
|
Amoxicillin Impurity T |
|
C16H19N3O5S |
|
Anastrozole iMpurity F |
|
|
|
Alogliptin Impurity 20 |
|
|
|
Alectinib Impurity |
1256584-83-4 |
C26H25N3O2 |
|
Afatinib ImpurityOYQ |
|
|
|
Anagrelide Impurity 2 HCl |
|
|
|
2,4(1H,3H)-Pyrimidinedione, 6-[(3R)-3-amino-1-piperidinyl]-3-methyl- |
2276323-24-9 |
C10H16N4O2 |
|
Azlocillin Opern-Ring Acetylation Impurity |
|
|
|
Anastrozole Impurity 19 |
1301724-97-9 |
C19H21N3O2 |
|
DEHYDROARIPIPRAZOLE, HYDROCHLORIDE |
1008531-60-9 |
C23H26Cl3N3O2 |
|
isopropyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
|
|
|
1,3-ジ-HABAカナマイシンA |
927821-99-6 |
C26H50N6O15 |
|
アゴメラテン二量體アセトアミド |
1385018-58-5 |
C28H29NO3 |
|
Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate] |
|
C50H60CaN2O10 |
|
2,3‐デヒドロシリビンB |
142796-24-5 |
C25H20O10 |
|
monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C24H28CaNO5 |
|
3-methyl-2-pentylphenol |
1823068-39-8 |
C12H18O |
|
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)- |
104146-11-4 |
C29H27N3O5S2 |
|
(2R-TRANS)-ジルチアゼム塩酸塩 |
103532-27-0 |
C22H27ClN2O4S |
|
2'-[(1H-テトラゾール-5-イル)ビフェニル-4-イル]メタノール |
160514-13-6 |
C14H12N4O |
|
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid |
1639970-62-9 |
C22H23NO4 |
|
Ofloxacin/Levofloxacin Impurity A |
|
|
|
(R,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
|
7-PACE Impurity 2 |
|
|
|
Desloratadine IMpurity 3 |
1346600-61-0 |
C19H19ClN2 |
|
EMpagliflozin iMpurity 11 |
|
|
|
LCZ Impurity |
753421-85-1 |
C20H25NO2 |
|
(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid |
|
C22H23NO4 |
|
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate |
|
C27H35NO5 |
|
Formoterol EP Impurity E |
1616967-26-0 |
C20H26N2O4 |
|
(Glu3)-Carbetocin (Impurity D) |
|
|
|
Δ3-7-ACT |
|
|
|
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |
|
(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1) |
|
|
|
ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate |
|
C26H33NO5 |
|
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
417722-95-3 |
C24H18ClN3O5 |
|
アカルボースD-フルクトース不純物 |
1013621-79-8 |
C25H43NO18 |
|
Apixaban iMpurity 1 |
|
|
|
Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-Benzenediacetic acid) |
1338800-81-9 |
C17H21N3O4 |
|
Alogliptin Impurity D |
1926163-25-8 |
C61H86N16O13 |
|
Alogliptin Related Compound 23 |
1618644-29-3 |
C20H13ClN4O2 |
|
Alogliptin Related Compound 26 |
865759-10-0 |
C25H24N6O2 |
|
Anastrozole Impurity 3 |
|
|
|
AcarBose EP Impurity B |
1220983-54-9 |
C26H43NO17 |
|
Alogliptin Impurity 17 |
|
|
|
N-(2-Chloro-ethyl)-N'-(2,3-dichloro-phenyl)-ethane-1,2-diamine |
|
C10H13Cl3N2 |
|
Afatinib impurity 43 |
|
|
|
Afatinib impurity 47 |
|
|
|
Afatinib Impurity 56 |
|
|
|
Agomelatine Impurity 11 |
|
|
|
Alogliptin Impurity 22 |
|
|
|
Afatinib Impurity YHQ |
|
|
|
Ethyl 4-bromo-3-hydroxybutyrate |
32224-01-4 |
C6H11BrO3 |
|
Afatinib impurity 84 |
|
|
|
Benzeneacetic acid, 3-(2-amino-1,1-dimethyl-2-oxoethyl)-α,α-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- |
2469244-33-3 |
C17H22N4O3 |
|
1,4-ビス[3,4-ジヒドロ-2(1H)-キノリノン-7-オキシ]ブタン |
882880-12-8 |
C22H24N2O4 |
|
Aripiprazole N,N-Dioxide |
573691-13-1 |
C23H27Cl2N3O4 |
|
7-クロロ-4-(4-ヒドロキシアニリノ)キノリン |
81099-86-7 |
C15H11ClN2O |
|
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetaMide) |
120512-03-0 |
C17H21N5O |